ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
Radboud University Medical Center at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Radboud University Medical Center takes part in 7 sessions at ESMO 2026 in Madrid. Its work spans lung and prostate cancer, biomarkers, and treatment response. It examines blood-based tumor DNA for genetic profiling and breath analysis to predict response in advanced lung cancer.
| Organization | ESMO 2026 Attendance |
|---|---|
Radboud University Medical Center Nijmegen, Netherlands | |
University medical centre in Nijmegen, Netherlands, combining a university hospital with the medical faculty of Radboud University. | Poster Fri Oct 23 13:00–15:00 Abstract Fri Oct 23 14:07–14:12 2220RO - Plasma ctDNA as standalone or adjunct to tumour tissue for HRR and PI3K/AKT genotyping in mCRPC: PROMPT (NCT04746300) Genitourinary cancersGastrointestinal cancers Poster Fri Oct 23 15:15–16:00 Poster Fri Oct 23 15:15–16:00 Final overall survival (OS) and biomarker analysis of ipilimumab plus nivolumab in molecularly selected metastatic castration-resistant prostate cancer (mCRPC): The INSPIRE trial Genitourinary cancersBiomarkers & precision oncology Talk Fri Oct 23 16:35–16:55 Emerging immune-based therapies Genitourinary cancers Talk Sun Oct 25 10:45–10:55 Poster Sun Oct 25 12:00–12:45 Poster Sun Oct 25 12:00–12:45 |
Find decision makers at Radboud University Medical Center
Tell us what you sell and we’ll find the people at Radboud University Medical Center most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction